COMMUNIQUÉS West-GlobeNewswire

Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017

08/03/2018 - 13:30

DALLAS and FORT WORTH, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]

Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results

08/03/2018 - 13:30

DUBLIN, Ireland, March 08, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL ), "Avadel" or "the Company," today announced its financial results for the fourth quarter and full year 2017. Highlights [...]

TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2017 Financial Results and Business Update

08/03/2018 - 13:30

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ) today announced its financial results for the fourth quarter and year ended December 31, 2017 and provided recent company developments [...]

Stemline Therapeutics to Present at Upcoming Investor Conferences

08/03/2018 - 13:30

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that [...]

Ossur Hf : New share option program

08/03/2018 - 13:05

Announcement no. 19/2018 Reykjavik, 8 March 2018 New share option program Enclosed information on a new share option program for the CEO and other members of the Executive Management, their direct reports (with [...]

Ossur Hf : Board decisions following the Annual General Meeting

08/03/2018 - 13:03

Announcement no. 18/2018 Reykjavik, 8 March 2018 Board decisions following the Annual General Meeting Enclosed are the Board decisions following the Annual General Meeting of Össur hf. held today, Thursday 8 March 2018 [...]

Aptose To Release Fourth Quarter and Year End December 31, 2017 Financial Results and Hold Conference Call on March 27, 2018

08/03/2018 - 13:00

SAN DIEGO and TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO ) (TSX: APS ), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated [...]

Melinta Therapeutics Partner, Menarini Group, Submits Marketing Authorization Application for Delafloxacin in Europe

08/03/2018 - 13:00

NEW HAVEN, Conn., March 08, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today [...]

Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2017 Financial Results

08/03/2018 - 13:00

NEWTOWN, Pa., March 08, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]

Ossur Hf : Results of the Annual General Meeting

08/03/2018 - 11:01

Announcement no. 17/2018 Reykjavik, 8 March 2018 Results of the Annual General Meeting Enclosed are the results of the Annual General Meeting of Össur hf. held today, Thursday 8 March 2018. The Icelandic Register of [...]

Affimed to Present at the Cowen and Company 38th Annual Health Care Conference

08/03/2018 - 11:00

Heidelberg, Germany, March 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi [...]

ViaDerma, Inc. Provides an Update of Current Marketing Activities

08/03/2018 - 11:00

LOS ANGELES, March 08, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), is pleased to provide an update of the Company’s current marketing activities: ViaDerma is in discussions with a Huntington Beach based [...]

Veritas Pharma Signs Letter of Intent with 3 Carbon Extractions Inc.

08/03/2018 - 09:10

VANCOUVER, British Columbia, March 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) (“Veritas” or the “Company”) is pleased to announce the signing of a non-binding Letter of [...]

C-RAD signs a contract for its GEMini portal imaging detector

08/03/2018 - 08:58

C-RAD announced today that it has signed an agreement with a Chinese company Beijing HGPT Technology & Trade Co., Ltd regarding the procurement and cooperation around the GEMini Portal imaging and dosimetry detector [...]

Execution, Growth and Increased Awareness

08/03/2018 - 08:42

In 2017, BioPorto remained focused on creating growth and ensuring tight execution of the top priorities in our strategic agenda; increasing awareness about the use of Neutrophil Gelatinase Associated Lipocalin (NGAL) [...]

Genmab A/S Summons Annual General Meeting

08/03/2018 - 08:26

Company Announcement Genmab A/S to hold Annual General Meeting on April 10, 2018 Copenhagen, Denmark; March 8, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) summons the Annual General Meeting on Tuesday, April 10, 2018 at [...]

Notice to convene Herantis Pharma Plc's Annual General Meeting of shareholders

08/03/2018 - 08:01

Notice to convene Herantis Pharma Plc's Annual General Meeting of shareholders Herantis Pharma Plc Company release 8 March 2018, 9:00 am NOTICE TO CONVENE HERANTIS PHARMA PLC'S ANNUAL GENERAL MEETING OF SHAREHOLDERS [...]

Evotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform

08/03/2018 - 07:47

Press Release Sources: Sanofi (EURONEXT: SAN) (NYSE: SNY) Evotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform Evotec-led platform open to academia, [...]

Evotec et Sanofi en négociations exclusives afin de créer, sous la direction d'Evotec, une plateforme R&D d'innovation ouverte dans les maladies infectieuses

08/03/2018 - 07:47

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Evotec et Sanofi en négociations exclusives afin de créer, sous la direction d'Evotec, une plateforme R&D d'innovation ouverte dans les maladies [...]